| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS, INC | SVP, Head of Development | Common Stock | 75,537 | $28,863 | $0.3821 | 25 Feb 2022 | Direct |
| SANGAMO THERAPEUTICS, INC | SVP, Head of Development | Stock Option (Right to Buy) | 110,700 | 25 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGMO | SANGAMO THERAPEUTICS, INC | 25 Feb 2022 | 2 | $0 | 4 | SVP, Head of Development | 01 Mar 2022, 16:20 |
| SGMO | SANGAMO THERAPEUTICS, INC | 12 Feb 2022 | 1 | -$31,467 | 4 | SVP, Head of Development | 24 Feb 2022, 16:32 |